In recent years, a hand full of AI startup companies that managed to utilize AI/ML to discover novel targets and/or design therapeutics reached human clinical trials and received massive media attention. However, there are several similar transformativ…
If FDA approval is granted, the company is likely to start human testing on the device in 2023.
Building this kind of standardization into the relatively black box nature of AI development is among the priorities of The Coalition for Health AI (CHAI), which launched earlier this year.
She worked in top labs at Stanford and Harvard. Now she wants to disrupt a 100-Billion-Dollar market by rejuvenating your skin using genetic engineering.
Jean Hébert believes the brain will soon be the only organ we cannot replace. But we can repair it.
As the body grows old, our minds are often instigated by mental decline and progressive, natural psychological aging. However, while there are very little we can do about biological aging, there are many ways to reverse psychological aging and get happ…
Aging is one single determinant of most diseases. In recent years, the biotechnology industry started using aging biology as a platform for drug discovery to discover and develop potentially blockbuster therapeutics. Dr. Michael Ringel of BCG presented…
The term Eroom’s law in pharma was coined by Dr. Jack Scannell and colleagues in 2012 in Nature Reviews Drug Discovery. It is the opposite of Moore’s law in semiconductors and states that the inflation-adjusted cost of developing a new drug roughly dou…
With the traditional pharmacy leaders, Walgreen’s and CVS, expanding virtual and in-person care, while Amazon and Walmart leverage their footprints and subscription models—the frontline healthcare wars are about to get even more competitive.
Michael Stefferson received his PhD in Physics from the University of Colorado before deciding to make the jump into machine learning (ML). Here’s why he did, and why AI can transform the future of telemental health.
